AI Therapeutics Company
AI Therapeutics develops drugs for rare diseases and cancer.
Last Funding Type:
Series C
Funding Status:
M&A
Headquarters:
Guilford, Connecticut, United States
Founded Date:
2013-01-01
Investor Type:
info@lamthera.com
Investment Stage:
N/A
Last Funding Date:
2017-03-30
Total Funding:
98000000
Technology:
['BioTech & HealthTech']
Employee Number:
51-100
Number Of Exists:
N/A
Estimated Revenue:
$1M to $10M
Investors Number:
2.0
Industry:
Medical BioTech